Immune Parameters in The Prognosis and Therapy Monitoring of Cutaneous Melanoma Patients: Experience, Role, and Limitations

Figure 14

Plasma level of IL-6 for all the investigated patients during follow-up, cross-line depicts the 10 pg/mL cut-off.